Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2687
Who is this for?
Show terms as
2Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome, also known as large granular lymphocyte (LGL) lymphocytosis with neutropenia, is a rare blood disorder. In this condition, the body has too few neutrophils (a type of white blood cell that fights bacterial infections) and too many large granular lymphocytes (another type of white blood cell). Large granular lymphocytes are a special group of immune cells that normally help fight viruses and cancer cells, but in this syndrome they multiply excessively and crowd out or suppress normal neutrophil production. The main concern with this disease is the low neutrophil count (neutropenia), which makes patients more vulnerable to frequent and sometimes serious bacterial infections. Patients may experience recurrent fevers, mouth sores, skin infections, and other infections that are hard to shake. Some patients also develop an enlarged spleen (splenomegaly) and may have associated autoimmune conditions, particularly rheumatoid arthritis. Fatigue is also a common complaint. Treatment typically focuses on managing the neutropenia and preventing infections. Immunosuppressive medications such as methotrexate, cyclophosphamide, or cyclosporine are commonly used to control the abnormal lymphocyte expansion and improve neutrophil counts. Growth factors like granulocyte colony-stimulating factor (G-CSF) may be used to boost neutrophil production. In some cases, the disease follows a chronic, indolent course, but careful monitoring is important because a small number of cases may progress to a more aggressive lymphoproliferative disorder.

Key symptoms:

Frequent bacterial infectionsLow neutrophil count (neutropenia)High number of large granular lymphocytes in the bloodRecurrent feversMouth sores or ulcersFatigue and tirednessEnlarged spleenJoint pain or swelling (sometimes linked to rheumatoid arthritis)Skin infectionsRecurrent respiratory infectionsNight sweatsUnexplained weight lossEasy bruising or bleeding in some cases

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

2 events
Aug 2024Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Institute of Hematology & Blood Diseases Hospital, China — PHASE2

TrialRECRUITING
Jan 2000National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia

Institute of Hematology & Blood Diseases Hospital, China

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome.

2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

2 recruitingView all trials with filters →
Phase 21 trial
Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia
Phase 2
Actively Recruiting
PI: Shuhua Yi, Doctor (Institute of Hematology & Blood Diseases Hospital,) · Sites: Tianjin, Tianjin Municipality · Age: 1899 yrs
Other1 trial
National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
Actively Recruiting
· Sites: Tianjin, Tianjin Municipality

No specialists are currently listed for Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Neutropenia-hyperlymphocytosis with large granular lymphocytes syndromeForum →

No community posts yet. Be the first to share your experience with Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome.

Start the conversation →

Latest news about Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome

No recent news articles for Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is my current neutrophil count, and how low is it compared to normal?,Which treatment do you recommend starting with, and what are the possible side effects?,How often will I need blood tests to monitor my condition?,What signs of infection should I watch for, and when should I go to the emergency room?,Is there a risk that my condition could become more aggressive over time?,Should I be tested for associated autoimmune conditions like rheumatoid arthritis?,Are there any clinical trials or newer treatments I should know about?

Common questions about Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome

What is Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome?

Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome, also known as large granular lymphocyte (LGL) lymphocytosis with neutropenia, is a rare blood disorder. In this condition, the body has too few neutrophils (a type of white blood cell that fights bacterial infections) and too many large granular lymphocytes (another type of white blood cell). Large granular lymphocytes are a special group of immune cells that normally help fight viruses and cancer cells, but in this syndrome they multiply excessively and crowd out or suppress normal neutrophil production. The main concer

How is Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome inherited?

Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome typically begin?

Typical onset of Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome?

Yes — 2 recruiting clinical trials are currently listed for Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.